Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery
- DOI
- 10.1155/2020/2604967
- Published
- 2020-06-11
- Container
- Mediators of Inflammation
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/2020/2604967,
title = {Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery},
author = {Song Zhang and ZongXiu Yin and WeiDong Qin and XiaoLi Ma and Yao Zhang and EnXiu Liu and YanBiao Chu},
year = {2020},
journal = {Mediators of Inflammation},
doi = {10.1155/2020/2604967},
url = {https://doi.org/10.1155/2020/2604967}
}RIS
TY - JOUR TI - Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery AU - Song Zhang AU - ZongXiu Yin AU - WeiDong Qin AU - XiaoLi Ma AU - Yao Zhang AU - EnXiu Liu AU - YanBiao Chu PY - 2020 JO - Mediators of Inflammation DO - 10.1155/2020/2604967 UR - https://doi.org/10.1155/2020/2604967 ER -
APA
Zhang, S., Yin, Z., Qin, W., Ma, X., Zhang, Y., Liu, E., & Chu, Y. (2020). Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery. Mediators of Inflammation. https://doi.org/10.1155/2020/2604967
Source records
- crossref · retrieved 2026-09-25T04:27:23.280Z